Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Imugene Ltd (IMU AU)
Watchlist
82
Analysis
Health Care
•
Australia
Imugene Limited is a health biotechnology development company. The Company manufactures vaccines for gastric and breast cancer treatments. Imugene operates in Europe and Australia.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Imugene Ltd
•
21 Sep 2021 09:37
ASX100/200 Index Rebalance Preview: Potential December Changes With Large Impact
There could be 1 change to the ASX100 and 5 changes to the ASX200 at the December rebalance. With a long M&A pipeline, there could be additional...
Brian Freitas
Follow
834 Views
Share
bullish
•
BYD Company
•
19 Sep 2021 07:20
Index Rebalance & ETF Flow Recap: STO/OSH, KEP/SPH, HHI, SET50, HSTECH, HSCI
This recap highlights Insights covering the index rebalance space in Asia as well as announcements that could result in index changes. We also look...
Brian Freitas
Follow
659 Views
Share
bullish
•
Steadfast
•
17 Aug 2021 18:58
ASX100/200/300 Index Rebalance Preview: Big Impact & Large Shorts
There are a lot of changes expected across the ASX100, 200 & 300 indices at the September rebalance. A lot of those stocks will have a large impact...
Brian Freitas
Follow
701 Views
Share
bullish
•
Imugene Ltd
•
12 Aug 2021 12:56
ASX300 Sep 2021 Index Rebalance Preview: Changes Galore
There could be 8 adds and 5 deletes to the ASX300 index at the September rebalance. The stocks have moved but the index is not very widely tracked,...
Brian Freitas
Follow
1.3k Views
Share
bullish
•
Imugene Ltd
•
16 Aug 2018 15:03
•
Issuer-paid
Imugene - Checkpoint inhibitor vaccine programme accelerated
Imugene has in-licenced a pipeline of B-cell vaccines that complements and advances its in-house programme. The deal has brought forward...
Edison Investment Research
Follow
155 Views
Share
First
Previous
11
12
13
14
15
16
17
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x